Ali Hashemi is the Co-Founder of Glucare and an investor in early-stage ventures at the intersection of health and technology, with a particular focus on applying deep learning and complex algorithms to solve challenging problems in healthcare. Ali was previously the founder of Amana Healthcare, the benchmark and fastest-growing continuum-of-care hospital platform in the Middle East, acquired by Mubadala Healthcare in 2018 in what was among the most significant deals in regional healthcare M&A. Ali previously founded and led the Middle East Healthcare Practice at Booz & Company, based out of Dubai. Before joining Booz&Co, Ali was a member of the Healthcare Practice and the Private Equity Practice at Bain & Company, based in New York City. Ali studied Medicine and received his MBA concurrently from McGill University. He received a B.S.E. with Distinction from Duke University with a dual major in BioMedical Engineering and Religion and a minor in Chemistry.